NCT03684005 is a NA clinical trial of MyPatientPal smartphone app in Cancer, sponsored by Felicity Harper.

Who is sponsoring NCT03684005?

NCT03684005 is sponsored by Felicity Harper.

What drugs are being tested in NCT03684005?

Interventions in NCT03684005: MyPatientPal smartphone app.

Is NCT03684005 still recruiting?

NCT03684005 is currently completed. Last updated 2 March 2021.

Last reviewed 2021-03-02 · How we verify

NCT03684005

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MyPatientPal: An App to Help Patients Manage Their Cancer Care

Completed NA Last updated 2 March 2021

What this trial tests

NA trial testing MyPatientPal smartphone app in Cancer in 40 participants. Completed in 11 October 2019.

Timeline

1 October 2018

Primary endpoint
8 October 2019

11 October 2019

Quick facts

Lead sponsor	Felicity Harper
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	40
Start date	1 October 2018
Primary completion	8 October 2019
Estimated completion	11 October 2019
Sites	1 location across United States

Drugs / interventions tested

MyPatientPal smartphone app

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Felicity Harper

Who can join

Adults 18 to 75, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MyPatientPal was developed in collaboration with both patient and oncologist stakeholders, is designed to facilitate such patient self-management through the daily reporting of side effects and medications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03684005 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Felicity Harper
Last refreshed: 2 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing